June 2025:  

Loma Therapeutics Receives Large Grand

We are thrilled that we have received the prestigeous Grand Solutions Grant.

The project partners, consisting of Loma Therapeutics, The Technical University of Denmark, and the Kingdom Hospital of Denmark, will combined receive 28.65M DKK, or 3.9M Euros. This will advance Loma Therapeutics immunotherapy treatment to the clinical stage, generate a deeper understanding of the immune-dynamics of HPV-positive oropharyngeal cancer, and to implement an HPV DNA-based monitoring system of all patients cured of primary HPV-positive oropharyngeal cancer in the east region of Denmark.

Of the total grant, Loma Therapeutics will recieve approximately 1.3M Euros directly.

We are very thankful for the support shown to us by the Innovation Foundation of Denmark, and look forward to getting started on the project.